Babafunso A. Adenuga, D. Kibuule, Kayode D. S. Bamitale
{"title":"在纳米比亚,从洛匹那韦加利托那韦到阿扎那韦加利托那韦的二线抗逆转录病毒治疗政策变化的中断时间序列分析","authors":"Babafunso A. Adenuga, D. Kibuule, Kayode D. S. Bamitale","doi":"10.4172/2376-0419.1000195","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":16700,"journal":{"name":"Journal of Pharmaceutical Care & Health Systems","volume":"21 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An Interrupted Time Series Analysis of the Second line Antiretroviral Policy Change from Lopinavir Boosted with Ritonavir to Atazanavir Boosted with Ritonavir Based Regimens in Namibia\",\"authors\":\"Babafunso A. Adenuga, D. Kibuule, Kayode D. S. Bamitale\",\"doi\":\"10.4172/2376-0419.1000195\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":16700,\"journal\":{\"name\":\"Journal of Pharmaceutical Care & Health Systems\",\"volume\":\"21 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmaceutical Care & Health Systems\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2376-0419.1000195\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Care & Health Systems","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2376-0419.1000195","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
An Interrupted Time Series Analysis of the Second line Antiretroviral Policy Change from Lopinavir Boosted with Ritonavir to Atazanavir Boosted with Ritonavir Based Regimens in Namibia